DMK Pharmaceuticals Corporation

24-10153

May 06, 2024
DMK Pharma Lands $3.2M Deal To Sell Drug In Ch. 11

Drugmaker DMK Pharmaceuticals Corp. informed a Delaware bankruptcy judge Monday that the debtor worked out a tentative agreement in its Chapter 11 case to sell an opioid overdose recovery treatment for nearly $3.2 million.
April 09, 2024
Ch. 11 Judge Tosses Calif. Drug Co.'s Bid To Stay Investor Suit

A Delaware bankruptcy judge declined Tuesday to apply the automatic stay in DMK Pharmaceuticals' Chapter 11 case to a shareholder's appeal of a Delaware Chancery Court decision before the state's top court, finding the reorganization wouldn't be severely impacted if the debtor tapped an insurance policy to fund its defense.
February 06, 2024
Drugmaker Eyes Ch. 11 Pivot In Bid To Stave Off Liquidation

DMK Pharmaceuticals told a Delaware bankruptcy judge Tuesday that it aims to stay financially afloat by narrowing its focus to drugs to combat the opioid crisis, but it won't know for another few weeks if the gamble to avoid a liquidation sale will pay off.
February 05, 2024
Biotech Co. Hits Ch. 11, Blames Drug Misfires, Criminal Case

DMK Pharmaceuticals has applied for Chapter 11 protection in Delaware, citing recent clinical trial failures and product recalls, as well as the government's allegation that a subsidiary engaged in criminal activities, as reasons for seeking bankruptcy relief.